Originally published byEU-Startups
Gate2Brain, a Spanish BioTech company developing a therapeutic candidate for aggressive paediatric and adult brain tumours, has announced a €7 million investment – the largest investment raised by the company to date. The investment represent a 30.4% equity stake and strategic partnership with Shilpa Biocare Pvt Ltd, a wholly owned subsidiary of Shilpa Medicare Limited. “Gate2Brain […]
The post Barcelona-based Gate2Brain secures €7 million to advance brain tumour candidate appeared first on EU-Startups.
🌐
More news from European UnionEuropean Union
EUROPE
Related News
‘None of us will do it alone’: European solidarity takes over VivaTech
1d ago
EU won't force publishers to grant dead video games an afterlife
10h ago
Britain sending Ukraine an extra 30,000 drones – now 150,000 all up
11h ago
Vienna’s SOMAREALITY secures over €3 million to power real-time cognitive monitoring through eye tracking
1d ago
Users claimed they’d never seen a spell checker and panicked at the sight of red squiggles
1d ago